Glioblastoma (GB) is the most common and aggressive primary malignant astrocytoma
correlated with poor patient survival. There are no curative treatments for GB, and it …

Glioblastoma multiform (GBM) is a malignant tumor cancer that originates from the star‐
shaped glial support tissues, namely astrocytes, and it is associated with a poor prognosis in …

Glioblastoma (GBM) is classified as a stage‐IV glioma. Unfortunately, there are currently no
curative treatments for GBM. Poly (rC)‐binding protein 1 (PCBP1) is a cytosolic iron …

2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin (TCDD) stands as one of the most potent halogenated
polycyclic hydrocarbons, known to inflict substantial cytotoxic effects on both animal and …

Boron has an important potential for facilitating biological activity and for use in
pharmaceutical drug design. Boron glycine monoester (BGM) and boron glycine diester …

Despite substantial investments in anti-glioblastoma (GBM) drug discovery over the last
decade, progress is limited to preclinical stages, with clinical studies frequently encountering …

In this study, the biological properties of novel borenium and borinium compounds in terms
of their oxidative, genotoxic, and cytotoxic effects were assessed on cultured human …

In recent years, it has been demonstrated that combinational therapies have shown
promising results in the treatment of triple negative breast cancer. However, the effect of the …

Infection of a wound is one of the most important reasons delaying the recovery of an injured
tissue. In this study, chitosan-based hydrogels were loaded with different concentrations of …

Objective The aim of our study is to investigate the cytotoxic, antioxidant, and antimicrobial
effects of newly synthesized boron compounds in U87MG glioblastoma cell treatment …